Therapeutics Stock Soars Over 500% After Declaring New Acquisition
Avalo Therapeutics' Bold Move: Acquiring Revolutionary Anti-IL-1β mAb & Securing Monumental Financing.
Disclaimer: All information presented is factual and up-to-date to the best of our knowledge as of March 28, 2024.